{"id":2310,"date":"2019-10-01T17:00:24","date_gmt":"2019-10-01T17:00:24","guid":{"rendered":"http:\/\/depts.washington.edu\/tlcart\/?p=2310"},"modified":"2019-11-06T01:53:38","modified_gmt":"2019-11-06T01:53:38","slug":"unitaid-advances-tlc-art-long-acting-therapy-program","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/tlcart\/unitaid-advances-tlc-art-long-acting-therapy-program\/","title":{"rendered":"Unitaid and TLC-ART Are Developing a Grant Agreement for Making Long-Acting HIV Medicines for Global Health"},"content":{"rendered":"<p><a href=\"https:\/\/unitaid.org\/#en\">Unitaid<\/a>, a part of the WHO, engaged the UW&#8217;s TLC-ART program for developing a grant agreement (GAD). It intends to accelerate the global impact of long-acting (LA) HIV medicines enabled by TLC-ART innovations. The project will transform current oral drugs into more effective, targeted LA therapies to improve patient appeal.<\/p>\n<p>Follow this link for additional information: <a href=\"https:\/\/unitaid.org\/assets\/R14_2019-e_MedinCell_UOL_UOW-proposals.pdf\">Unitaid Resolution 14-2019-e<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-2318\" src=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/logo-1.png\" alt=\"\" width=\"346\" height=\"82\" srcset=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/logo-1.png 346w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/logo-1-300x71.png 300w\" sizes=\"auto, (max-width: 346px) 100vw, 346px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Unitaid, a part of the WHO, engaged the UW&#8217;s TLC-ART program for developing a grant agreement (GAD). It intends to accelerate the global impact of long-acting (LA) HIV medicines enabled by TLC-ART innovations. The project will transform current oral drugs into more effective, targeted LA therapies to improve patient appeal.<\/p>\n<div><a class=\"more-link\" href=\"https:\/\/depts.washington.edu\/tlcart\/unitaid-advances-tlc-art-long-acting-therapy-program\/\">Continue reading <span class=\"screen-reader-text\">Unitaid and TLC-ART Are Developing a Grant Agreement for Making Long-Acting HIV Medicines for Global Health<\/span><\/a><\/div>\n","protected":false},"author":4,"featured_media":2317,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2310","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/comments?post=2310"}],"version-history":[{"count":17,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2310\/revisions"}],"predecessor-version":[{"id":2398,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2310\/revisions\/2398"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/media\/2317"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/media?parent=2310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/categories?post=2310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/tags?post=2310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}